Theranos, the Silicon Valley biotech startup, was poised to revolutionize the health care industry — or at least that was its promise by CEO Elizabeth Holmes. With its finger-prick diagnostic technology, the company claimed it could screen for hundreds of diseases and deliver faster, more accurate results than conventional lab methods. But a series of articles in the Wall Street Journal by John Carreyrou uncovered an astounding tale of corporate fraud and deception. He chronicles the rise and fall of Theranos in his new book, Bad Blood: Secrets and Lies in a Silicon Valley Startup.
Photo by Michael Lionstar